** Sagar Sandesh print version ceases to be published from December 31, 2017. New look E-paper would be available from Jan. 1, 2018 onwards. free of cost.**

Impact of GST has largely been positive and constructive on Pharma Sector: Mansukh Mandaviya

Minister of State for Road Transport, Highways, Shipping and Chemicals & Fertilizers, Shri Mansukh Mandaviya has said in a statement that the impact of GST has been positive and constructive on Pharma sector.

The Minister gives details to establish the positive impact of GST on pharma sector such as the annual turnover of the Pharma sector, the exports and the annual drug approvals before and after GST.

Minister Mandaviya attributed this positive impact post-GST to removal of complexity of taxes, ease of doing business resulting in decrease in manufacturing cost and creation of a single market under ‘One Nation, One Tax’ regime for all stakeholders with equal chance towards development.

To go into details:

Before GST, Annual Turnover of the Pharma Sector (as on 31.05.2017) was Rs 1,14,231 crores while after GST, the Annual Turnover of Pharma sector (as on 31.05.2018) touched Rs 1,31,312 crores, which is 6% higher than the Pre-GST regime.

Exports from Pharma Sector during 2016-17 were Rs 2,75,852 crores while post-GST, in the year 2017-18, they were recorded at Rs 3,03,526 crores, which is 10% higher than the Pre-GST Regime. The Minister added that as per estimates, the export figure for the current year is likely to be Rs 3,27,700 crores, which will be almost 12% higher than the export figure of Pre-GST regime (2016-17).

Further, it was informed that there has been a significant jump in number of Drug Approvals from 7,857 before GST (01.07.2016 to 30.06.2017) to 10,446 post-GST (01.07.2017 to 30.06.2018). 

Shri Mandaviya informed that due to discontinuation of Central Sales Tax post-GST, it will reduce transaction costs, as inter-state transaction between two dealers will become tax neutral. Now, the pharma companies can consolidate their warehouses at strategic locations, effecting a reduction in cost of distribution. As a result, it will benefit warehouse strategy and improve supply chain efficiency in pharma sector, the Minister explained.

Disclaimer
Copyright © 2018 PORT TO PORT - Shipping Services Portal ( Sagar Sandesh ). All rights reserved.

Follow Us